UCL Business
London, Englanduclb.com
Overview
UCL Business Ltd (UCLB) is the wholly-owned commercialisation company of University College London (UCL). It is dedicated to bringing the university's world-class research, intellectual property, and innovations to market. UCLB facilitates this by forming and investing in spin-out companies, licensing technologies to industry partners, and managing investment funds. The firm focuses on opportunities arising from UCL's research base, particularly in life sciences, physical sciences, engineering, and healthcare.
Portfolio Companies
8
Website
uclb.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Gigaton | Jun 2026 | Series A | Co-investor |
| Panda Surgical | Sep 2025 | Strategic | Co-investor |
| Hologen | Jul 2025 | VC Round | Co-investor |
| Echopoint Medical Ltd | Feb 2024 | Series A | Co-investor |
| Engitix Therapeutics | Nov 2018 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.